Literature DB >> 29797287

Estimating renal function in patients with atrial fibrillation: which dose of direct oral anticoagulants?

Nicoletta Riva1, Walter Ageno2, Alex Gatt3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29797287     DOI： 10.1007/s11739-018-1883-1

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  18 in total

1.  Variations in clinical management of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation according to different equations for estimating renal function : Post hoc analysis of a prospective cohort.

Authors:  Vincenzo Livio Malavasi; Daniele Pettorelli; Elisa Fantecchi; Cristina Zoccali; Giuliana Laronga; Tommaso Trenti; Gregory Yoke Hong Lip; Giuseppe Boriani
Journal:  Intern Emerg Med       Date:  2018-05-07       Impact factor: 3.397

2.  Italian intersociety consensus on DOAC use in internal medicine.

Authors:  Domenico Prisco; Walter Ageno; Cecilia Becattini; Armando D'Angelo; Giovanni Davì; Raimondo De Cristofaro; Francesco Dentali; Giovanni Di Minno; Anna Falanga; Gualberto Gussoni; Luca Masotti; Gualtiero Palareti; Pasquale Pignatelli; Roberto M Santi; Francesca Santilli; Mauro Silingardi; Antonella Tufano; Francesco Violi
Journal:  Intern Emerg Med       Date:  2017-02-13       Impact factor: 3.397

Review 3.  Pros and cons of vitamin K antagonists and non-vitamin K antagonist oral anticoagulants.

Authors:  Nicoletta Riva; Walter Ageno
Journal:  Semin Thromb Hemost       Date:  2015-02-19       Impact factor: 4.180

4.  Relationship of gender, age, and body mass index to errors in predicted kidney function.

Authors:  Massimo Cirillo; Pietro Anastasio; Natale G De Santo
Journal:  Nephrol Dial Transplant       Date:  2005-07-05       Impact factor: 5.992

Review 5.  Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Salim S Virani; Clifton W Callaway; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Stephanie E Chiuve; Mary Cushman; Francesca N Delling; Rajat Deo; Sarah D de Ferranti; Jane F Ferguson; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Pamela L Lutsey; Jason S Mackey; David B Matchar; Kunihiro Matsushita; Michael E Mussolino; Khurram Nasir; Martin O'Flaherty; Latha P Palaniappan; Ambarish Pandey; Dilip K Pandey; Mathew J Reeves; Matthew D Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Uchechukwu K A Sampson; Gary M Satou; Svati H Shah; Nicole L Spartano; David L Tirschwell; Connie W Tsao; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2018-01-31       Impact factor: 29.690

6.  Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation.

Authors:  C Becattini; M Giustozzi; M G Ranalli; G Bogliari; F Cianella; M Verso; G Agnelli; M C Vedovati
Journal:  J Thromb Haemost       Date:  2018-03-26       Impact factor: 5.824

7.  Dabigatran versus warfarin in patients with atrial fibrillation.

Authors:  Stuart J Connolly; Michael D Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S Lewis; Harald Darius; Hans-Christoph Diener; Campbell D Joyner; Lars Wallentin
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

8.  Renal function in atrial fibrillation patients switched from warfarin to a direct oral anticoagulant.

Authors:  Anum S Minhas; Qingmei Jiang; Xiaokui Gu; Brian Haymart; Eva Kline-Rogers; Steve Almany; Jay Kozlowski; Gregory D Krol; Scott Kaatz; James B Froehlich; Geoffrey D Barnes
Journal:  J Thromb Thrombolysis       Date:  2016-11       Impact factor: 2.300

9.  Edoxaban versus warfarin in patients with atrial fibrillation.

Authors:  Robert P Giugliano; Christian T Ruff; Eugene Braunwald; Sabina A Murphy; Stephen D Wiviott; Jonathan L Halperin; Albert L Waldo; Michael D Ezekowitz; Jeffrey I Weitz; Jindřich Špinar; Witold Ruzyllo; Mikhail Ruda; Yukihiro Koretsune; Joshua Betcher; Minggao Shi; Laura T Grip; Shirali P Patel; Indravadan Patel; James J Hanyok; Michele Mercuri; Elliott M Antman
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

10.  Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes.

Authors:  Giuseppe Boriani; Cécile Laroche; Igor Diemberger; Mircea Ioachim Popescu; Lars Hvilsted Rasmussen; Lucian Petrescu; Harry J G M Crijns; Luigi Tavazzi; Aldo P Maggioni; Gregory Y H Lip
Journal:  Sci Rep       Date:  2016-07-28       Impact factor: 4.379
View more
  3 in total

1.  A focus on direct oral anticoagulants: "old" and possible new indications and efforts for a better clinical management.

Authors:  Domenico Prisco
Journal:  Intern Emerg Med       Date:  2018-09-21       Impact factor: 3.397

Review 2.  Efficacy and Safety of Non-Vitamin K Anticoagulants for Atrial Fibrillation in Relation to Different Renal Function Levels: A Network Meta-Analysis.

Authors:  Hao Jin; Kongbo Zhu; Lina Wang; Yifan Li; Jingjun Meng; Hong Zhi
Journal:  Cardiovasc Ther       Date:  2020-04-22       Impact factor: 3.023

3.  Kidney Function According to Different Equations in Patients Admitted to a Cardiology Unit and Impact on Outcome.

Authors:  Vincenzo Livio Malavasi; Anna Chiara Valenti; Sara Ruggerini; Marcella Manicardi; Carlotta Orlandi; Daria Sgreccia; Marco Vitolo; Marco Proietti; Gregory Y H Lip; Giuseppe Boriani
Journal:  J Clin Med       Date:  2022-02-08       Impact factor: 4.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.